Related references
Note: Only part of the references are listed.walK and clpP Mutations Confer Reduced Vancomycin Susceptibility in Staphylococcus aureus
Mitsutaka Shoji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Whole Genome Sequencing and Complete Genetic Analysis Reveals Novel Pathways to Glycopeptide Resistance in Staphylococcus aureus
Adriana Renzoni et al.
PLOS ONE (2011)
An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus
Longzhu Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Benjamin P. Howden et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Regulation of Hemolysin Expression and Virulence of Staphylococcus aureus by a Serine/Threonine Kinase and Phosphatase
Kellie Burnside et al.
PLOS ONE (2010)
Development of Reduced Vancomycin Susceptibility in Methicillin-Susceptible Staphylococcus aureus
Satish K. Pillai et al.
CLINICAL INFECTIOUS DISEASES (2009)
Modulation of Cell Wall Structure and Antimicrobial Susceptibility by a Staphylococcus aureus Eukaryote-Like Serine/Threonine Kinase and Phosphatase
Amanda M. Beltramini et al.
INFECTION AND IMMUNITY (2009)
Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
Adina C. Musta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Reduced Susceptibility to Vancomycin Influences Pathogenicity in Staphylococcus aureus Infection
Anton Y. Peleg et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Sensitive, specific polymorphism discovery in bacteria using massively parallel sequencing
Chad Nusbaum et al.
NATURE METHODS (2009)
Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus
Benjamin P. Howden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia
Benjamin P. Howden et al.
BMC MICROBIOLOGY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance
Hui-Min Neoh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA
Rong Wang et al.
NATURE MEDICINE (2007)
Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus
Melanie R. Stapleton et al.
JOURNAL OF BACTERIOLOGY (2007)
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus
Michael Meehl et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus
Andrea Jansen et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii
Anton Y. Peleg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing
Michael M. Mwangi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
YycH and YycI interact to regulate the essential YycFG two-component system in Bacillus subtilis
Hendrik Szurmant et al.
JOURNAL OF BACTERIOLOGY (2007)
Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacterernia
Benjamin P. Howden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Allelic replacement in Staphylococcus aureus with inducible counter-selection
T Bae et al.
PLASMID (2006)
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Use of within-array replicate spots for assessing differential expression in microarray experiments
GK Smyth et al.
BIOINFORMATICS (2005)
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility
BP Howden et al.
CLINICAL INFECTIOUS DISEASES (2004)
Identification of genes controlled by the essential YycG/YycF two-component system of Staphylococcus aureus
S Dubrac et al.
JOURNAL OF BACTERIOLOGY (2004)
Failure of vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections
BP Howden et al.
CLINICAL INFECTIOUS DISEASES (2004)
TcaR, a putative MarR-like regulator of sarS expression
N McCallum et al.
JOURNAL OF BACTERIOLOGY (2004)
Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus
M Kuroda et al.
MOLECULAR MICROBIOLOGY (2003)
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene
S Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001
SK Fridkin et al.
CLINICAL INFECTIOUS DISEASES (2003)
Normalization of cDNA microarray data
GK Smyth et al.
METHODS (2003)
Genetic analysis and functional characterization of the Streptococcus pneumoniae vic operon
C Wagner et al.
INFECTION AND IMMUNITY (2002)
Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice
LV Collins et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)
MC Enright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation
BT Bateman et al.
INFECTION AND IMMUNITY (2001)
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
M Wootton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Inactivation of a novel three-cistronic operon tcaR-tcaA-tcaB increases teicoplanin resistance in Staphylococcus aureus
M Brandenberger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2000)
Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
